Advantages and limitations of metaanalytic regressions of clinical trials data.
OBJECTIVE
To focus on methodology of metaregression and demonstrate to clinicians, through 2 published examples, some strengths and limitations. EXAMPLE 1


METHODS
Metaanalysis of data from 20 years of randomized trials of lidocaine prophylaxis in preventing primary ventricular fibrillation (VF) in myocardial infarction used separate data for control and active-treatment groups to model the risk of VF as a function of year of publication and other study characteristics. EXAMPLE 1


RESULTS
Collinearity between pairs of predictor variables can lead to difficulty in interpreting logistic regression models. EXAMPLE 2


METHODS
Metaanalysis of data from 7 trials (323 patients) measured treatment effect of immunosuppressive therapy for acute Crohn's disease by response-rate difference (RD, experimental minus control group). EXAMPLE 2


RESULTS
Weighted least-squares regression models of the RD suggested an association between RD and various study characteristics, but collinearity again led to difficulty in interpretation of multiple regression results.


CONCLUSIONS
Warning signs of colinearity include: large pairwise correlations between predictor variables, large changes in coefficients caused by the addition or deletion of other variables, and extremely large SEs for coefficients. Suggestions for coping with collinearity include: removing redundant variables from the model, reducing reliance on interpretation of coefficients for confounding variables, forming one or more summary variables, centering the data, collecting more data, and using more sophisticated regression methods.


CONCLUSIONS
Metaanalysis can explore variations in as well as summarize results of randomized trials. Although metaregression has advantages, study characteristics are often strongly associated with each other, leading to collinearity.
Berlin
J A
JA
University of Pennsylvania School of Medicine, Center for Clinical Epidemiology and Biostatistics, Philadelphia 19104-6095.
Antman
E M
EM
D000208:Acute Disease; D015986:Confounding Factors, Epidemiologic; D003424:Crohn Disease / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D016018:Least-Squares Analysis; D008012:Lidocaine / Q000627:therapeutic use; D016015:Logistic Models; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000150:complications; D016017:Odds Ratio; D016032:Randomized Controlled Trials as Topic; D012044:Regression Analysis; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control
D008012:Lidocaine